The post Oracle and Ci4CC Collaborate to Enhance AI in Cancer Research appeared on BitcoinEthereumNews.com. Rongchai Wang Nov 07, 2025 11:54 Oracle Health and Ci4CC are collaborating to advance AI-driven oncology care and research, aiming to integrate clinical and genomic data for personalized medicine solutions. Oracle Health and Life Sciences has announced a strategic partnership with the Cancer Center Informatics Society (Ci4CC), a nonprofit organization that brings together cancer centers, researchers, and industry innovators. This collaboration is aimed at accelerating artificial intelligence (AI) innovation in oncology care and research, according to Oracle. Advancing Oncology Care The partnership will leverage Oracle’s advanced technological capabilities alongside Ci4CC’s Initiatives Program and its expansive network of National Cancer Institute (NCI)-Designated and Community Care Cancer Centers. Together, the organizations aim to design an electronic health record (EHR) system optimized specifically for cancer care. Seema Verma, Executive Vice President and General Manager of Oracle Health and Life Sciences, emphasized the importance of AI and data science in combating cancer, a leading cause of death worldwide. Verma noted that by combining Ci4CC’s expertise and network with Oracle’s AI-powered healthcare solutions, the collaboration could significantly accelerate discoveries that may contribute to curing cancer. Innovative Approaches in Clinical Research The collaboration seeks to foster initiatives across various facets of oncology care and clinical research. This includes the integration of clinical and genomic data to create personalized medicine solutions, development of AI-driven approaches for clinical trial innovation and drug development, and the establishment of comprehensive real-world evidence frameworks aimed at advancing precision oncology platforms. Sorena Nadaf-Rahrov, President & CEO of the Cancer Center Informatics Society, regards the alliance with Oracle as a pivotal moment for Ci4CC. Nadaf-Rahrov highlighted that advancements in cancer research and clinical care are best achieved through collaborative networks, which are central to Ci4CC’s mission. Data-Driven Health Innovations By integrating Oracle’s state-of-the-art AI technology… The post Oracle and Ci4CC Collaborate to Enhance AI in Cancer Research appeared on BitcoinEthereumNews.com. Rongchai Wang Nov 07, 2025 11:54 Oracle Health and Ci4CC are collaborating to advance AI-driven oncology care and research, aiming to integrate clinical and genomic data for personalized medicine solutions. Oracle Health and Life Sciences has announced a strategic partnership with the Cancer Center Informatics Society (Ci4CC), a nonprofit organization that brings together cancer centers, researchers, and industry innovators. This collaboration is aimed at accelerating artificial intelligence (AI) innovation in oncology care and research, according to Oracle. Advancing Oncology Care The partnership will leverage Oracle’s advanced technological capabilities alongside Ci4CC’s Initiatives Program and its expansive network of National Cancer Institute (NCI)-Designated and Community Care Cancer Centers. Together, the organizations aim to design an electronic health record (EHR) system optimized specifically for cancer care. Seema Verma, Executive Vice President and General Manager of Oracle Health and Life Sciences, emphasized the importance of AI and data science in combating cancer, a leading cause of death worldwide. Verma noted that by combining Ci4CC’s expertise and network with Oracle’s AI-powered healthcare solutions, the collaboration could significantly accelerate discoveries that may contribute to curing cancer. Innovative Approaches in Clinical Research The collaboration seeks to foster initiatives across various facets of oncology care and clinical research. This includes the integration of clinical and genomic data to create personalized medicine solutions, development of AI-driven approaches for clinical trial innovation and drug development, and the establishment of comprehensive real-world evidence frameworks aimed at advancing precision oncology platforms. Sorena Nadaf-Rahrov, President & CEO of the Cancer Center Informatics Society, regards the alliance with Oracle as a pivotal moment for Ci4CC. Nadaf-Rahrov highlighted that advancements in cancer research and clinical care are best achieved through collaborative networks, which are central to Ci4CC’s mission. Data-Driven Health Innovations By integrating Oracle’s state-of-the-art AI technology…

Oracle and Ci4CC Collaborate to Enhance AI in Cancer Research

2 min read


Rongchai Wang
Nov 07, 2025 11:54

Oracle Health and Ci4CC are collaborating to advance AI-driven oncology care and research, aiming to integrate clinical and genomic data for personalized medicine solutions.

Oracle Health and Life Sciences has announced a strategic partnership with the Cancer Center Informatics Society (Ci4CC), a nonprofit organization that brings together cancer centers, researchers, and industry innovators. This collaboration is aimed at accelerating artificial intelligence (AI) innovation in oncology care and research, according to Oracle.

Advancing Oncology Care

The partnership will leverage Oracle’s advanced technological capabilities alongside Ci4CC’s Initiatives Program and its expansive network of National Cancer Institute (NCI)-Designated and Community Care Cancer Centers. Together, the organizations aim to design an electronic health record (EHR) system optimized specifically for cancer care.

Seema Verma, Executive Vice President and General Manager of Oracle Health and Life Sciences, emphasized the importance of AI and data science in combating cancer, a leading cause of death worldwide. Verma noted that by combining Ci4CC’s expertise and network with Oracle’s AI-powered healthcare solutions, the collaboration could significantly accelerate discoveries that may contribute to curing cancer.

Innovative Approaches in Clinical Research

The collaboration seeks to foster initiatives across various facets of oncology care and clinical research. This includes the integration of clinical and genomic data to create personalized medicine solutions, development of AI-driven approaches for clinical trial innovation and drug development, and the establishment of comprehensive real-world evidence frameworks aimed at advancing precision oncology platforms.

Sorena Nadaf-Rahrov, President & CEO of the Cancer Center Informatics Society, regards the alliance with Oracle as a pivotal moment for Ci4CC. Nadaf-Rahrov highlighted that advancements in cancer research and clinical care are best achieved through collaborative networks, which are central to Ci4CC’s mission.

Data-Driven Health Innovations

By integrating Oracle’s state-of-the-art AI technology with real-world data from Ci4CC’s network of cancer centers, the collaboration aims to transform data into actionable knowledge that can redefine cancer research and improve patient care. This strategic partnership is part of a non-binding agreement, indicating a flexible yet committed approach to achieving their shared objectives.

Image source: Shutterstock

Source: https://blockchain.news/news/oracle-ci4cc-collaborate-enhance-ai-cancer-research

Market Opportunity
null Logo
null Price(null)
--
----
USD
null (null) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

XAU/USD picks up, nears $4,900 in risk-off markets

XAU/USD picks up, nears $4,900 in risk-off markets

The post XAU/USD picks up, nears $4,900 in risk-off markets  appeared on BitcoinEthereumNews.com. Gold (XAU/USD) is trimming some losses on Friday, trading near
Share
BitcoinEthereumNews2026/02/06 20:32
Altcoin Season Incoming? Lyno AI Presale Buzz Surpasses Dogecoin and Shiba Inu Hype

Altcoin Season Incoming? Lyno AI Presale Buzz Surpasses Dogecoin and Shiba Inu Hype

The post Altcoin Season Incoming? Lyno AI Presale Buzz Surpasses Dogecoin and Shiba Inu Hype appeared on BitcoinEthereumNews.com. The altcoin season is picking up in September 2025, as the bitcoin dominance declines, and new opportunities emerge. The hype surrounding Lyno AI is currently more frenzied than the hype surrounding Dogecoin ETF and Shiba Inu meme-driven pumps. This trend is an indicator of increasing popularity of AI-based altcoins that have practical use. Lyno AI Early Bird Stage Heating Up. Early Bird sale by Lyno AI has brought in revenue of 31,462 and sold 632,398 tokens priced at 0.050. The second presale will raise the price to $0.055 and closer to the final target price of $0.100 per token. Customers who spend more than 100 dollars have an opportunity to win a portion of Lyno AI $100K giveaway that is divided into ten prizes worth 10K each. This incentive encourages a high start-up demand. Why Lyno AI is the leader in Altseason Hype. The difference between Lyno AI and other projects is its refined AI-driven cross-chain arbitrage engine, which is focused on democratizing trading, which in most cases is controlled by big organizations. Lyno AI takes advantage of retail investors by allowing them to invest in profitable opportunities once unavailable to them due to real-time market insights and automated execution on 15+ blockchains, such as Ethereum and BNB Chain. The smart contracts are audited and multi-layered, which increases trustworthiness. Arbitrage opportunities are searched by the AI algorithms of the platform in milliseconds, allowing to optimize the routes and eliminate such factors as slippage and gas fees. The community will determine the future of the protocol by laying control in the hands of the $LYNO token holders, and the long-term participation is incited by the staking rewards. This agriculture infrastructure and high presale dynamics makes Lyno AI the leader of this altseason wave. Act Fast Before the Surge Investors must not…
Share
BitcoinEthereumNews2025/09/19 15:16
The 1inch team's investment fund withdrew 20 million 1INCH tokens, worth $1.86 million, from Binance.

The 1inch team's investment fund withdrew 20 million 1INCH tokens, worth $1.86 million, from Binance.

PANews reported on February 6 that, according to on-chain analyst Yu Jin, the 1inch team's investment fund withdrew 20 million 1INCH (US$1.86 million) from Binance
Share
PANews2026/02/06 19:58